Upcoming Webinars

May 20 at 1 PM

Supporting Cancer Recovery and Reducing Recurrence: The Role of Integrative Oncology

Join Goodpath and MunichRe for a webinar that will explore an overlooked challenge in cancer care: non-adherence.

Non-adherence to recommended cancer treatment is surprisingly common — and costly. This session will spotlight the latest data on why patients skip or discontinue treatment, and how integrative oncology can make a measurable difference in outcomes.

You’ll learn about:

• The surprising prevalence and drivers of cancer treatment non-adherence

• How whole-person support can improve treatment completion, return-to-work rates, and survival

• What employers and insurers can do to better support members facing cancer

Hear from a panel of leading experts:

• Dr. Sara Char, Clinical Fellow in Hematology and Oncology, Dana-Farber Cancer Institute

• Dr. Daniel Hall, Clinical Health Psychologist, Massachusetts General Hospital

• Eleni Pitaridis, Senior Account Manager, Munich Re

May 28 at 2 PM

Goodpath Monthly Demo

During this live webinar, you will: 

• Learn about Goodpath's whole-person approach to care for chronic conditions

• Understand the benefits of Goodpath for employees and employers across industries, like healthcare, manufacturing and financial services

• See the health outcomes and medical savings Goodpath is driving for employers and how we measure ROI

May 20 at 1 PM

Supporting Cancer Recovery and Reducing Recurrence: The Role of Integrative Oncology

Join Goodpath and MunichRe for a webinar that will explore an overlooked challenge in cancer care: non-adherence.

Non-adherence to recommended cancer treatment is surprisingly common — and costly. This session will spotlight the latest data on why patients skip or discontinue treatment, and how integrative oncology can make a measurable difference in outcomes.

You’ll learn about:

• The surprising prevalence and drivers of cancer treatment non-adherence

• How whole-person support can improve treatment completion, return-to-work rates, and survival

• What employers and insurers can do to better support members facing cancer

Hear from a panel of leading experts:

• Dr. Sara Char, Clinical Fellow in Hematology and Oncology, Dana-Farber Cancer Institute

• Dr. Daniel Hall, Clinical Health Psychologist, Massachusetts General Hospital

• Eleni Pitaridis, Senior Account Manager, Munich Re